FIELD: pharmaceutics. SUBSTANCE: composition of solid dosed forms consists of (a) active substance chosen out of valsartan and, not obligatory, out of HCTZ, and (b) pharmaceutically acceptable additives useful in manufacturing solid oral dosed forms due to pressing. It is, also, suggested the method to manufacture solid oral dosed form. The innovation provides to obtain oral tabletted composition due to simple and reliable method, moreover, solid oral dosed form has got small size despite the quantity of active substance incorporated. EFFECT: higher efficiency. 26 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID ORAL DOSAGE FORMS OF VALSARTAN | 2007 |
|
RU2453306C2 |
VALSARTAN-BASE SOLID ORAL DOSING FORMULATIONS | 1997 |
|
RU2294743C2 |
PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2333757C2 |
GALENA COMPOSITION OF ALISKIREN AND HYDROCHLOROTHIAZIDE | 2007 |
|
RU2491058C2 |
SOLID PERORAL DOSED OUT FORMS OF VALSARTAN | 2005 |
|
RU2361575C2 |
USING RECEPTOR AT-1 ANTAGONIST OR RECEPTOR AT-2 MODULATOR IN TREATMENT OF DISEASES ASSOCIATED WITH INCREASE CONTENT OF AT-1 OR AT-2 RECEPTORS | 1999 |
|
RU2271809C2 |
TABLET WITH FILM COATING CONTAINING OXACARBAZEPINE | 1998 |
|
RU2201218C2 |
PHARMACEUTICAL COMPOSITIONS | 2000 |
|
RU2330666C2 |
METHOD FOR PRODUCTION OF MULTIPARTICLES USING ROLLER COMPACTOR | 2007 |
|
RU2451504C2 |
FLUVASTATIN CONTAINING PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2297223C2 |
Authors
Dates
2003-04-27—Published
1997-06-18—Filed